UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Hanlin Wang, MD, PhD

Print
Email

Hanlin L Wang, MD, PhD

UCLA Physician Hanlin L  Wang, MD, PhD specializes in Anatomic Pathology & Clinical Pathology.
Specialty
Anatomic Pathology & Clinical Pathology
Gender
Male
Language Spoken
English, Chinese (Mandarin)
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
C52688
Contact
(310) 206-1763
Voted Best Doctor
PRACTICE LOCATION

Department of Pathology & Laboratory Medicine
10833 Le Conte Avenue, 13-145 CHS
Los Angeles, CA 90095-1672

MEDICAL BOARD CERTIFICATION
Anatomic Pathology & Clinical Pathology, American Board of Pathology, 2000
EDUCATION
Fellowship
GI/Liver Pathology, University of Chicago Hospitals, 2000 - 2001
Residency
Anatomic & Clinical Pathology, University of Chicago Hospitals, 1996 - 2000
Medical Degree
MD, Wuhan University School of Medicine, 1982
MORE INFORMATION
Research Interest
Medical and neoplastic gastrointestinal and hepatic diseases
Additional Information

Academic Title: Professor; Program Director, GI/Liver Fellowship, Pathology & Lab Medicine

Dr. Hanlin L. Wang is a Professor at the David Geffen School of Medicine and a Gastrointestinal/Liver Pathology faculty. He received his medical degree from the Wuhan University School of Medicine in China and his Ph.D. in Biomedical Sciences from the Mayo Clinic in Minnesota. He completed his pathology residency and Gastrointestinal/Liver Pathology fellowship at the University of Chicago Hospitals. Dr. Wang is board-certified in Anatomic and Clinical Pathology. He has authored more than 100 journal articles, numerous book chapters and invited reviews, and 1 pathology textbook (co-editor). He has been an invited speaker at numerous national and international meetings and serves on the editorial boards for several pathology/medical journals. Dr. Wang was Director of Gastrointestinal Pathology at Cedars-Sinai Medical Center and an Associate Professor at Washington University Barnes-Jewish Hospital in St. Louis before joining UCLA. His clinical and research interests include medical and neoplastic gastrointestinal and liver diseases.

Publications
  1. Liapis H, Wang HL (editors). Pathology of Solid Organ Transplantation. Springer, Heidelberg, 2011.
  2. Lamps LW, Misdraji J, Yerian L, Despande V, Kim GE, Meno-Kenudson M, Kakar S, Wang HL, Yeh MM, Caradine KD. Diagnostic Pathology: Hepatobiliary and Pancreatic. Amirsys Publishing, Inc., 2011.
  3. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DP, Brown GD, Underhill DM. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012; 336(6086):1314-1317.
  4. Fleming M, Ravula S, Tatishchev S, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012; 3:153-173.
  5. Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, Lassman C, Anders RA, Misdraji J, Yerian LM, Xu H, Dhall D, Wang HL. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol. 2012; 43:695-701.
  6. Schmidt MT, Himmelfarb EA, Shafi H, Lin F, Xu H, Wang HL. Use of IMP3, S100P and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy. Appl Immunohistochem Mol Morphol. 2012; 20:478-487.
  7. Tretiakova M, Antic T, Westerhoff M, Mueller J, Himmelfarb EA, Wang HL, Xiao SY. Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions. Am J Surg Pathol. 2012; 36:101-108.
  8. Fan L, Levy M, Aguilar CE, Mertens RB, Dhall D, Frishberg DP, Wang HL. Lymph node retrieval from colorectal resection specimens for invasive adenocarcinoma: is it worth the extra effort to find at least 12 nodes? Colorectal Dis. 2011; 13:1377-1383.
  9. Wang HL, Lopategui J, Amin MB, Patterson SD. KRAS mutation testing in human cancers: the pathologist’s role in the era of personalized medicine. Adv Anat Pathol. 2010; 17:23-32.
  10. Levy M, Lin F, Xu H, Dhall D, Spaulding BO, Wang HL. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol. 2010; 41:1210-1219.
  11. Berman D, Parker SM, Siegel J, Chasalow SD, Weber J, Galbraith S, Targan SR, Wang HL. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun. 2010; 10:11.
  12. Nasseri Y, Melmed G, Wang HL, Targan S, Fleshner P. Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis. Am J Gastroenterol. 2010; 105:155-161.
  13. Kahn ME, French S, Wang HL. Hepatocellular adenoma: morphological and molecular variants and distinction from well-differentiated hepatocellular carcinoma. Pathol Case Rev. 2009; 14:13-20.
  14. Wang HL, Dhall D. Goblet or signet ring cells: that is the question. Adv Anat Pathol. 2009; 16:247-254.
  15. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol. 2008; 32:1816-1821.
  16. Wang HL, Anatelli F, Zhai J, Adley B, Chuang ST, Yang XJ. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med. 2008; 132:1723-1728.
  17. Suh N, Liapis H, Misdraji J, Brunt EM, Wang HL. Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction and immunohistochemistry on liver biopsy from immunocompetent patients. Am J Surg Pathol. 2007; 31:1403-1409.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Hanlin L Wang,  click here to update your profile.